- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07943364
Transcutaneous Auricular Vagus Nerve Stimulation in Perimenopause
Transcutaneous Auricular Vagus Nerve Stimulation in Perimenopause: EEG Signatures of Symptom Modulation
The study will test an ear-based nerve stimulation (taVNS) to see if it can ease common perimenopause symptoms like hot flashes, poor sleep, mood changes, and "brain fog". Along the way, brain activity (EEG) and heart rhythm patterns (HRV) will be tracked to find simple, reliable signs of improvement.
Because women with both mild and more severe symptoms early in the transition are included, the results can learn who benefits most and why. If successful, this study will set the stage for larger trials and could make taVNS a low-risk, affordable option to support women's brain and overall health during perimenopause.
Studieoversigt
Status
Betingelser
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Ikke anvendelig
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion criteria:
- Perimenopausal women aged 35-60 with climacteric symptoms for >6 months, irregular menstruation, and at least one menses in the past 6 months.
- Women on menopausal hormone therapy (HRT).
- Ability to understand procedures and provide informed consent.
- Willingness to complete study visits, questionnaires, EEG/HRV recordings, taVNS sessions.
- Negative urine pregnancy test.
- Access to stable internet for remote sessions or willingness to use study-provided equipment.
Exclusion criteria:
- Pregnancy, breastfeeding, or planning pregnancy during the active study period (for randomized subjects).
- Postmenopausal status.
- History of implanted stimulator.
- Clinically significant unstable cardiac disease.
- History of seizure disorder or serious neurological condition that interferes with study procedures or EEG interpretation.
- Current ear infection.
- Active severe psychiatric instability.
- Recent initiation or major dose change of hormone therapy, psychotropics, beta-blockers, anticholinergics, or other medications likely to substantially affect autonomic or symptom outcomes.
- Current participation in another interventional trial that could confound outcomes.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Tredobbelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Active Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)
|
Transcutaneous auricular vagus nerve stimulation (taVNS) is a non-invasive neuromodulation technique that delivers mild electrical stimulation to the external ear at regions innervated by the auricular branch of the vagus nerve. |
|
Placebo komparator: Sham Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)
|
tAVNS device with electrode placed at the external ear at regions with no active current. |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Electroencephalography (EEG)
Tidsramme: Baseline (Visit 2, pre-intervention) and Post Intervention (Visit 13, around 2 weeks from V2)
|
Resting Electroencephalography (EEG) will be recorded using a 64-channel system (resting alpha/theta power) |
Baseline (Visit 2, pre-intervention) and Post Intervention (Visit 13, around 2 weeks from V2)
|
Samarbejdspartnere og efterforskere
Datoer for undersøgelser
Studer store datoer
Studiestart (Anslået)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Andre undersøgelses-id-numre
- 2026P001468
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .